ASPARAGINASE,L: (114820)

Compound Details

NameASPARAGINASE,L:
Compound class18300
Compound codePROTEID

Summary

Compound class: 18300

Experiments: 18

View Experiments

Experiments (18)

Filters
Worktypes (19)
14
9
5
4
3
3
3
2
2
1
1
1
1
1
1
1
1
1
1
No match
Pharmacology (5)
3
2
1
1
11
No match
Compounds (111)
18
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
No match
Organisms (16)
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
No match
18 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)
327373
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
ANTITUMOR ACTIVITY
Escherichia coli (ENTEROBACTERIACEAE)
1026861
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Capsicum annuum (SOLANACEAE)
319432
PURIFICATION OFWORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESWORK DESCRIBED MAINLY CONCERNS METHODOLOGYAFFINITY CHROMATOGRAPHY USEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
Escherichia coli (ENTEROBACTERIACEAE)
319469
PHARMACOLOGY OF COMPOUND - IN HUMANSANTICANCER AND/OR CYTOTOXICITY MARKER CODEREVIEW OF
IMMUNOSUPPRESSANT ACTIVITY
Empty organism
318640
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESWORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Escherichia coli (ENTEROBACTERIACEAE)
973598
ISOLATION AND IDENTIFICATION OF
Lupinus arboreus (FABACEAE)
1090991
PHARMACOLOGY OF COMPOUND - IN VIVO
DELAYED TYPE CUTANEOUS HYPERSENSITIVITY INHIBITION
Empty organism
318505
METABOLISM STUDYMECHANISM OF ACTION STUDIEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEREVIEW OF
Empty organism
614610
ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)TLC DATA REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
Empty organism
319137
GEL PERMEATION CHROMATOGRAPHY USEDPURIFICATION OFPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
Empty organism
1173357
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Empty organism
327374
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
ANTITUMOR ACTIVITY
Escherichia coli (ENTEROBACTERIACEAE)
319431
PURIFICATION OFWORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESWORK DESCRIBED MAINLY CONCERNS METHODOLOGYAFFINITY CHROMATOGRAPHY USEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
Pseudomonas aeruginosa (PSEUDOMONADACEAE)
336015
ANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
Pseudomonas ovalis (PSEUDOMONADACEAE)
836471
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODEREVIEW OF
ANTITUMOR ACTIVITY
Empty organism
331432
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION OFQUANTITATIVE DATA REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
Empty organism
332853
ANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
Escherichia coli (ENTEROBACTERIACEAE)
1173358
PHARMACOLOGY OF COMPOUND - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGSANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Empty organism
Show SPARQL Queries (1)